药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Glucosamine
Antithrombin Alfa
The risk or severity of bleeding can be increased when Antithrombin Alfa is combined with Ponatinib.
Glucosamine
Zinc citrate
The risk or severity of bleeding can be increased when Zinc citrate is combined with Ponatinib.
Glucosamine
Desirudin
The risk or severity of bleeding can be increased when Desirudin is combined with Ponatinib.
Glucosamine
Parnaparin
The risk or severity of bleeding can be increased when Parnaparin is combined with Ponatinib.
Glucosamine
Bemiparin
The risk or severity of bleeding can be increased when Bemiparin is combined with Ponatinib.
Glucosamine
Dextran
The risk or severity of bleeding can be increased when Dextran is combined with Ponatinib.
Glucosamine
Sodium citrate
The risk or severity of bleeding can be increased when Sodium citrate is combined with Ponatinib.
Glucosamine
Potassium citrate
The risk or severity of bleeding can be increased when Potassium citrate is combined with Ponatinib.
Glucosamine
Ditazole
The risk or severity of bleeding can be increased when Ditazole is combined with Ponatinib.
Glucosamine
Nadroparin
The risk or severity of bleeding can be increased when Nadroparin is combined with Ponatinib.
Glucosamine
Ferulic acid
The risk or severity of bleeding can be increased when Ferulic acid is combined with Ponatinib.
Glucosamine
Tinzaparin
The risk or severity of bleeding can be increased when Tinzaparin is combined with Ponatinib.
Glucosamine
Dalteparin
The risk or severity of bleeding can be increased when Dalteparin is combined with Ponatinib.
Glucosamine
Danaparoid
The risk or severity of bleeding can be increased when Danaparoid is combined with Ponatinib.
Glucosamine
Amediplase
The risk or severity of bleeding can be increased when Amediplase is combined with Ponatinib.
Glucosamine
Otamixaban
The risk or severity of bleeding can be increased when Otamixaban is combined with Ponatinib.
Glucosamine
Astaxanthin
The risk or severity of bleeding can be increased when Astaxanthin is combined with Ponatinib.
Glucosamine
Idraparinux
The risk or severity of bleeding can be increased when Idraparinux is combined with Ponatinib.
Glucosamine
Semuloparin
The risk or severity of bleeding can be increased when Semuloparin is combined with Ponatinib.
Glucosamine
Sulodexide
The risk or severity of bleeding can be increased when Sulodexide is combined with Ponatinib.